3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Status
Recruiting
7
Unknown
4
Completed
3
Terminated
2
Active not recruiting
2
Not yet recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
56
Carcinoma, Non-Small-Cell Lung
35
Breast Neoplasms
29
Neoplasm Metastasis
23
Glioblastoma
23
Colonic Neoplasms
23
Rectal Neoplasms
19
Ovarian Neoplasms
16
Neoplasms
15
Brain Neoplasms
12
Lung Neoplasms
11
Pancreatic Neoplasms
10
Glioma
10
Fallopian Tube Neoplasms
10
Carcinoma, Renal Cell
10
Carcinoma, Hepatocellular
9
Gliosarcoma
7
Adenocarcinoma of Lung
7
Kidney Neoplasms
6
Liver Neoplasms
5
Astrocytoma
5
Sarcoma
4
Recurrence
4
Oligodendroglioma
4
Melanoma
4
Uterine Cervical Neoplasms
3
Lymphoma, Non-Hodgkin
3
Leukemia, Myeloid, Acute
3
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Interventions
Capecitabine
3
Fluorouracil
2
Cetuximab
2
Bevacizumab
2
aflibercept
1
Panitumumab
1
Oxaliplatin
1
Nivolumab
1
Methotrexate
1
Leucovorin
1
Hypnosis
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Colorectal Cancer Metastatic
×
Bevacizumab
×
Clear all
NCT06332079
2026-01-05
HAITI
Gruppo Oncologico del Nord-Ovest
Phase 2
Terminated
4 enrolled
NCT05589597
2025-08-22
AUDREY
Enterome
Phase 1/2
Terminated
25 enrolled